What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Medical Device

Drug Delivery Devices Ophthalmic Drug

PUBLISHER: 360iResearch | PRODUCT CODE: 1594656

PUBLISHER: 360iResearch | PRODUCT CODE: 1594656

Ophthalmic Drug Delivery System Market by Technology (Contact Lenses, Episcleral Implants, Eye Drops), Production Technology (3D Printing, Compression Molding, Electrospinning), Material, Delivery Route - Global Forecast 2025-2030

PUBLISHED: October 31, 2024

PAGES: 195 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The Ophthalmic Drug Delivery System Market was valued at USD 16.35 billion in 2023, expected to reach USD 17.85 billion in 2024, and is projected to grow at a CAGR of 9.59%, to USD 31.04 billion by 2030.

The ophthalmic drug delivery system encompasses a range of technologies and methods designed to deliver drugs to the eye for treating ocular conditions and diseases. This segment is pivotal in the pharmaceutical and healthcare industry due to the eye's unique anatomy and the challenges in achieving effective drug concentration in targeted areas. The necessity for such systems arises from conditions like glaucoma, macular degeneration, dry eye syndrome, and post-surgical care, where conventional systemic drug delivery methods fall short in efficacy. Various delivery systems, such as eye drops, ointments, injections, and implants, are tailored to improve bioavailability and patient compliance. Key end-users include hospitals, ophthalmic clinics, and homecare settings.

KEY MARKET STATISTICS
Base Year [2023]	USD 16.35 billion
Estimated Year [2024]	USD 17.85 billion
Forecast Year [2030]	USD 31.04 billion
CAGR (%)	9.59%

The market is primarily driven by the rising prevalence of eye disorders, an aging population, and advancements in drug formulations and delivery technologies. Developments such as nanotechnology and biodegradable drug-eluting implants present lucrative opportunities for innovation, offering enhanced therapeutic outcomes and patient adherence. However, growth is tempered by factors like high R&D costs, stringent regulatory requirements, and the complex nature of ocular biology that limits drug penetration. Moreover, patient compliance remains a challenge, especially with chronic administration requirements.

To capitalize on emerging opportunities, companies should focus on research to develop non-invasive, patient-friendly delivery systems and invest in novel drug formulations. Collaboration with academic institutions and biotech firms can spur innovation in delivery mechanisms and materials, thus expanding therapeutic potential. Despite existing challenges, advancements in personalized medicine and the integration of digital health technologies could position ophthalmic drug delivery systems as a cornerstone of future ocular therapies. It's crucial for businesses to navigate regulatory landscapes and optimize cost structures to remain competitive in this rapidly evolving market, which requires continuous evolution of strategies aligned with technological progress and patient needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ophthalmic Drug Delivery System Market

The Ophthalmic Drug Delivery System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Rising number of eye disorders in geriatric population
- Increasing preference for early diagnosis and prevention
- Growing government initiatives for eye care
Market Restraints
- Associated complications of ophthalmic drug delivery systems
Market Opportunities
- Ongoing advancements in ophthalmic drug delivery system
- Favorable reimbursement policies
Market Challenges
- Concern regarding poor bioavailability and instability for dissolved drugs

Porter's Five Forces: A Strategic Tool for Navigating the Ophthalmic Drug Delivery System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ophthalmic Drug Delivery System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ophthalmic Drug Delivery System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ophthalmic Drug Delivery System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ophthalmic Drug Delivery System Market

A detailed market share analysis in the Ophthalmic Drug Delivery System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ophthalmic Drug Delivery System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ophthalmic Drug Delivery System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Ophthalmic Drug Delivery System Market

A strategic analysis of the Ophthalmic Drug Delivery System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmic Drug Delivery System Market, highlighting leading vendors and their innovative profiles. These include AptarGroup, Inc., Bausch Health Companies Inc., Biocorp, Envisia Therapeutics, EyePoint Pharmaceuticals, Inc., Gerresheimer AG, Mati Therapeutics, Inc., Merck & Co., Novartis AG, Ocular Therapeutix Inc., Oculis Pharma, Owen Mumford, Pfizer Inc., Terumo Corporation, and Teva Pharmaceuticals.

Market Segmentation & Coverage

This research report categorizes the Ophthalmic Drug Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Technology, market is studied across Contact Lenses, Episcleral Implants, Eye Drops, Hydrogels, Injectable Particulate Systems, Intravitreal Implants, Iontophoresis, Micro-Electromechanical, Microneedles, Nano Careers, Nano Microparticles, and Punctal Plugs.
Based on Production Technology, market is studied across 3D Printing, Compression Molding, Electrospinning, Extrusion, Formulation, and Micro Patterning.
Based on Material, market is studied across Collagen, Fatty acids, Hydrogels, Liposomes, PDO/PVA, PLA-PEG, PLGA, Polycaprolactone, Polyorthoesters, and TMC.
Based on Delivery Route, market is studied across Intracameral, Intraocular, and Intravitreal.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-742BD51829D7

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising number of eye disorders in geriatric population
  - 5.1.1.2. Increasing preference for early diagnosis and prevention
  - 5.1.1.3. Growing government initiatives for eye care
- 5.1.2. Restraints
  - 5.1.2.1. Associated complications of ophthalmic drug delivery systems
- 5.1.3. Opportunities
  - 5.1.3.1. Ongoing advancements in ophthalmic drug delivery system
  - 5.1.3.2. Favorable reimbursement policies
- 5.1.4. Challenges
  - 5.1.4.1. Concern regarding poor bioavailability and instability for dissolved drugs
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Ophthalmic Drug Delivery System Market, by Technology

6.1. Introduction
6.2. Contact Lenses
6.3. Episcleral Implants
6.4. Eye Drops
6.5. Hydrogels
6.6. Injectable Particulate Systems
6.7. Intravitreal Implants
6.8. Iontophoresis
6.9. Micro-Electromechanical
6.10. Microneedles
6.11. Nano Careers
6.12. Nano Microparticles
6.13. Punctal Plugs

7. Ophthalmic Drug Delivery System Market, by Production Technology

7.1. Introduction
7.2. 3D Printing
7.3. Compression Molding
7.4. Electrospinning
7.5. Extrusion
7.6. Formulation
7.7. Micro Patterning

8. Ophthalmic Drug Delivery System Market, by Material

8.1. Introduction
8.2. Collagen
8.3. Fatty acids
8.4. Hydrogels
8.5. Liposomes
8.6. PDO/PVA
8.7. PLA-PEG
8.8. PLGA
8.9. Polycaprolactone
8.10. Polyorthoesters
8.11. TMC

9. Ophthalmic Drug Delivery System Market, by Delivery Route

9.1. Introduction
9.2. Intracameral
9.3. Intraocular
9.4. Intravitreal

10. Americas Ophthalmic Drug Delivery System Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Ophthalmic Drug Delivery System Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Ophthalmic Drug Delivery System Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation

Companies Mentioned

1. AptarGroup, Inc.
2. Bausch Health Companies Inc.
3. Biocorp
4. Envisia Therapeutics
5. EyePoint Pharmaceuticals, Inc.
6. Gerresheimer AG
7. Mati Therapeutics, Inc.
8. Merck & Co.
9. Novartis AG
10. Ocular Therapeutix Inc.
11. Oculis Pharma
12. Owen Mumford
13. Pfizer Inc.
14. Terumo Corporation
15. Teva Pharmaceuticals

Product Code: MRR-742BD51829D7

LIST OF FIGURES

FIGURE 1. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET RESEARCH PROCESS
FIGURE 2. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
FIGURE 11. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET DYNAMICS
TABLE 7. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CONTACT LENSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY EPISCLERAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE PARTICULATE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAVITREAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY IONTOPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRO-ELECTROMECHANICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY NANO CAREERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY NANO MICROPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PUNCTAL PLUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY 3D PRINTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COMPRESSION MOLDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTROSPINNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRO PATTERNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PDO/PVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PLA-PEG, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PLGA, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYORTHOESTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TMC, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRACAMERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAOCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAVITREAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 55. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 58. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 62. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 77. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 80. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 81. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 84. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 89. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 92. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 116. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 126. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 129. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 130. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 133. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 134. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 137. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 141. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 142. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 145. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 146. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 150. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 153. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 154. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 158. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 162. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 165. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 166. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 169. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 170. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 173. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 186. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 189. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 190. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 193. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 194. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 198. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 201. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 210. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
TABLE 211. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023